切换至 "中华医学电子期刊资源库"

中华普通外科学文献(电子版) ›› 2023, Vol. 17 ›› Issue (01) : 14 -17. doi: 10.3877/cma.j.issn.1674-0793.2023.01.003

述评

重视肝胆胰外科患者的肌肉减少症问题
马金栋1, 陈强谱1,(), 卢艳敏2   
  1. 1. 256600 滨州医学院附属医院肝胆外科;256600 滨州医学院附属医院临床营养科
    2. 256600 滨州医学院附属医院临床营养科
  • 收稿日期:2022-10-08 出版日期:2023-02-01
  • 通信作者: 陈强谱
  • 基金资助:
    山东省临床重点专科建设基金资助项目(SLCZDZK-0701); 山东省胆胰肿瘤精品特色专科建设基金资助项目(SLCZDZK-2401)

Focus on sarcopenia in hepatobiliary and pancreatic surgery

Jindong Ma1, Qiangpu Chen1(), Yanmin Lu2   

  • Received:2022-10-08 Published:2023-02-01
  • Corresponding author: Qiangpu Chen
引用本文:

马金栋, 陈强谱, 卢艳敏. 重视肝胆胰外科患者的肌肉减少症问题[J]. 中华普通外科学文献(电子版), 2023, 17(01): 14-17.

Jindong Ma, Qiangpu Chen, Yanmin Lu. Focus on sarcopenia in hepatobiliary and pancreatic surgery[J]. Chinese Archives of General Surgery(Electronic Edition), 2023, 17(01): 14-17.

骨骼肌是人体最大的器官,约占体质量的40%,对机体的运动和代谢功能至关重要。1989年Rosenberg首次提出了"肌肉减少症"的概念。目前肌肉减少症已被确认为一种独立疾病,并有相应的国际疾病编码(ICD-10-AM)。2010年欧洲老年人肌肉减少症工作组(European Working Group on Sarcopenia in Older People,EWGSOP)将其正式定义为"一种进行性的骨骼肌肌量和强度广泛损失,导致机体四肢功能障碍、生活质量下降、死亡等不良事件风险增加的综合征"[1]。随着老龄化社会的到来,肝胆胰外科患者肌肉减少症问题日益凸显,导致术后并发症增加、住院时间延长、生存率降低等,也引起了外科医师的关注[2]。本文就肝胆胰外科患者肌肉减少症的相关问题进行讨论。

[1]
蔡婷婷, 王蕾, 陈强谱. 肌肉减少症对老年患者术后并发症的影响及干预措施[J]. 中华老年医学杂志, 2021, 40(8): 971-975.
[2]
Yokoyama Y, Nagino M, Ebata T. Importance of "muscle" and "intestine" training before major HPB surgery: A review[J]. J Hepatobiliary Pancreat Sci, 2021, 28(7): 545-555.
[3]
Kitamura A, Seino S, Abe T, et al. Sarcopenia: prevalence, associated factors, and the risk of mortality and disability in Japanese older adults[J]. J Cachexia Sarcopenia Muscle, 2021, 12(1): 30-38.
[4]
Chen Z, Li WY, Ho M, et al. The prevalence of sarcopenia in Chinese older adults: meta-analysis and meta-regression[J]. Nutrients, 2021, 13(5): 1441.
[5]
Tandon P, Montano-Loza AJ, Lai JC, et al. Sarcopenia and frailty in decompensated cirrhosis[J]. J Hepatol, 2021, 75 Suppl 1: S147-S162.
[6]
Takada H, Kurosaki M, Nakanishi H, et al. Impact of pre-sarcopenia in sorafenib treatment for advanced hepatocellular carcinoma[J]. PLoS One, 2018, 13(6): e0198812.
[7]
Chakedis J, Spolverato G, Beal EW, et al. Pre-operative sarcopenia identifies patients at risk for poor survival after resection of biliary tract cancers[J]. J Gastrointest Surg, 2018, 22(10): 1697-1708.
[8]
王蕾, 蔡婷婷, 胡凤爱, 等. 梗阻性黄疸合并肌肉减少症的相关影响因素[J]. 滨州医学院学报, 2022, 45(2): 130-133.
[9]
Kuan LL, Dennison AR, Garcea G. Prevalence and impact of sarcopenia in chronic pancreatitis: A review of the literature[J]. World J Surg, 2021, 45(2): 590-597.
[10]
Latorre Fragua RA, Manuel Vázquez A, Ramiro Pérez C, et al. Influence of sarcopenia in major pancreatic surgery. A systematic review of the literature[J]. Gastroenterol Hepatol, 2020, 43(3): 142-154.
[11]
Malmstrom TK, Morley JE. SARC-F: A simple questionnaire to rapidly diagnose sarcopenia[J]. J Am Med Dir Assoc, 2013, 14(8): 531-532.
[12]
魏强, 陈强谱, 卢艳敏. 营养评估的几种影像学方法及应用[J/CD]. 中华普通外科学文献(电子版), 2019, 13(5): 341-344.
[13]
Cruz-Jentoft AJ, Bahat G, Bauer J, et al. Sarcopenia: revised European consensus on definition and diagnosis[J]. Age Ageing, 2019, 48(1): 16-31.
[14]
杜妍妍, 魏强, 陈强谱. B型超声在测量机体瘦体组织含量中的应用[J]. 中华临床营养杂志, 2016, 24(5): 316-320.
[15]
杜妍妍, 陈强谱, 孙宝房, 等. 利用人体成分分析仪检测围手术期患者体液含量及分布变化的临床意义[J/CD]. 中华普通外科学文献(电子版), 2018, 12(4): 223-227.
[16]
Rodriguez-Mañas L, Araujo de Carvalho I, Bhasin S, et al. ICFSR Task Force perspective on biomarkers for sarcopenia and frailty[J]. J Frailty Aging, 2020, 9(1): 4-8.
[17]
Tantai X, Liu Y, Yeo YH, et al. Effect of sarcopenia on survival in patients with cirrhosis: A meta-analysis[J]. J Hepatol, 2022, 76(3): 588-599.
[18]
Voron T, Tselikas L, Pietrasz D, et al. Sarcopenia impacts on short- and long-term results of hepatectomy for hepatocellular carcinoma[J]. Ann Surg, 2015, 261(6): 1173-1183.
[19]
Denbo JW, Kim BJ, Vauthey JN, et al. Overall body composition and sarcopenia are associated with poor liver hypertrophy following portal vein embolization[J]. J Gastrointest Surg, 2021, 25(2): 405-410.
[20]
王蕾, 卢艳敏, 冀海斌, 等. 肌肉减少症对肝切除术后患者预后影响的Meta分析[J]. 现代肿瘤医学, 2021, 29(20): 3600-3604.
[21]
Lee EC, Park SJ, Lee SD, et al. Effects of sarcopenia on prognosis after resection of gallbladder cancer[J]. J Gastrointest Surg, 2020, 24(5): 1082-1091.
[22]
Yu H, Wang M, Wang Y, et al. The prognostic value of sarcopenia combined with preoperative fibrinogen-albumin ratio in patients with intrahepatic cholangiocarcinoma after surgery: A multicenter, prospective study[J]. Cancer Med, 2021, 10(14): 4768-4780.
[23]
Okumura S, Kaido T, Hamaguchi Y, et al. Visceral adiposity and sarcopenic visceral obesity are associated with poor prognosis after resection of pancreatic cancer[J]. Ann Surg Oncol, 2017, 24(12): 3732-3740.
[24]
Sakamoto T, Yagyu T, Uchinaka E, et al. Sarcopenia as a prognostic factor in patients with recurrent pancreatic cancer: A retrospective study[J]. World J Surg Oncol, 2020, 18(1): 221.
[25]
Pessia B, Giuliani A, Romano L, et al. The role of sarcopenia in the pancreatic adenocarcinoma[J]. Eur Rev Med Pharmacol Sci, 2021, 25(10): 3670-3678.
[26]
Kim IH, Choi MH, Lee IS, et al. Clinical significance of skeletal muscle density and sarcopenia in patients with pancreatic cancer undergoing first-line chemotherapy: A retrospective observational study[J]. BMC Cancer, 2021, 21(1): 77.
[27]
陈强谱, 冀海斌, 魏强. 加速康复外科理念下围手术期营养管理[J/CD]. 中华普通外科学文献(电子版), 2018, 12(5): 289-291.
[28]
Weimann A, Braga M, Carli F, et al. ESPEN guideline: clinical nutrition in surgery[J]. Clin Nutr, 2017, 36(3): 623-650.
[29]
Deutz NE, Bauer JM, Barazzoni R, et al. Protein intake and exercise for optimal muscle function with aging: recommendations from the ESPEN Expert Group[J]. Clin Nutr, 2014, 33(6): 929-936.
[30]
孙建琴, 张坚, 常翠青, 等. 肌肉衰减综合征营养与运动干预中国专家共识(节录)[J]. 营养学报, 2015, 37(4): 320-324.
[31]
Liberman K, Njemini R, Luiking Y, et al. Thirteen weeks of supplementation of vitamin D and leucine-enriched whey protein nutritional supplement attenuates chronic low-grade inflammation in sarcopenic older adults: the PROVIDE study[J]. Aging Clin Exp Res, 2019, 31(6): 845-854.
[32]
Plauth M, Bernal W, Dasarathy S, et al. ESPEN guideline on clinical nutrition in liver disease[J]. Clin Nutr, 2019, 38(2): 485-521.
[33]
Kitajima Y, Takahashi H, Akiyama T, et al. Supplementation with branched-chain amino acids ameliorates hypoalbuminemia, prevents sarcopenia, and reduces fat accumulation in the skeletal muscles of patients with liver cirrhosis[J]. J Gastroenterol, 2018, 53(3): 427-437.
[34]
Saiman Y, Serper M. Frailty and sarcopenia in patients pre- and post-liver transplant[J]. Clin Liver Dis, 2021, 25(1): 35-51.
[35]
Furbetta N, Comandatore A, Gianardi D, et al. Perioperative nutritional aspects in total pancreatectomy: A comprehensive review of the literature[J]. Nutrients, 2021, 13(6): 1765.
[36]
Bibby N, Griffin O. Nutritional considerations for the management of the older person with hepato-pancreatico-biliary malignancy[J]. Eur J Surg Oncol, 2021, 47(3 Pt A): 533-538.
[37]
Tandon P, Ismond KP, Riess K, et al. Exercise in cirrhosis: translating evidence and experience to practice[J]. J Hepatol, 2018, 69(5): 1164-1177.
[38]
Nilwik R, Snijders T, Leenders M, et al. The decline in skeletal muscle mass with aging is mainly attributed to a reduction in type Ⅱ muscle fiber size[J]. Exp Gerontol, 2013, 48(5): 492-498.
[39]
吴倩倩, 方秀新, 吕小芹, 等. 基于加速康复外科理念的肺康复干预对腹部手术患者的影响[J]. 齐鲁护理杂志, 2020, 26(24): 5-8.
[40]
Davis MP, Panikkar R. Sarcopenia associated with chemotherapy and targeted agents for cancer therapy[J]. Ann Palliat Med, 2019, 8(1): 86-101.
[41]
Tang G, Zhang L, Tao J, et al. Effects of perioperative probiotics and synbiotics on pancreaticoduodenectomy patients: A meta-analysis of randomized controlled trials[J]. Front Nutr, 2021, 8: 715788.
No related articles found!
阅读次数
全文


摘要